Table TDI-19. Primary drug of clients entering treatment, 2008 or most recent year available [see all tables in this series...]

Part (iv) All inpatient clients by country and primary drug (%)

Country		Opioids	Cocaine	Stimulants	Hypnotics/ sedatives	Hallucinogens	Volatile substances	Cannabis	Other substances	Drug known (n)	Drug unknown	Total
Belgium	(1)	44.9	14.0	15.6	1.9	0.5	0.0	23.0	0.1	1304	106	1410
Bulgaria		98.8	0.0	1.2	0.0	0.0	0.0	0.0	0.0	503	0	503
Czech Rep.		27.7	0.2	59.6	1.0	0.0	0.8	10.2	0.4	2159	0	2159
Denmark		41.5	5.0	14.0	5.0	0.0	0.0	30.6	4.0	301	27	328
Germany		44.0	8.9	9.9	3.8	0.2	0.1	20.6	12.5	5633	0	5633
Estonia
Ireland		51.4	17.8	2.1	3.5	0.0	0.3	24.5	0.3	1072	0	1072
Greece		92.2	3.4	0.1	1.3	0.0	0.0	2.8	0.2	1931	0	1931
Spain
France		61.2	15.7	1.0	7.3	0.8	0.5	12.9	0.5	381	74	455
Italy
Cyprus		69.9	20.5	0.0	0.0	0.0	0.0	9.6	0.0	83	0	83
Latvia		60.0	0.0	17.7	4.6	0.3	2.6	12.8	2.1	725	78	803
Lithuania
Luxembourg		75.9	19.5	1.1	1.1	1.1	0.0	1.1	0.0	87	0	87
Hungary		28.8	3.6	12.2	22.1	1.4	2.7	11.3	18.0	222	0	222
Malta
Netherlands
Austria		83.6	7.8	2.3	1.9	0.3	0.0	4.0	0.0	1165	187	1352
Poland	(2)									0	12582	12582
Portugal
Romania		74.2	0.3	0.5	11.7	0.2	0.7	2.4	10.1	1522	0	1522
Slovenia
Slovakia		32.7	0.5	31.3	7.3	0.2	8.8	19.3	0.0	658	90	748
Finland		57.3	0.5	21.9	10.8	0.0	0.2	9.3	0.1	873	0	873
Sweden		38.4	1.5	32.7	13.5	0.2	0.2	11.3	2.3	2497	0	2497
United Kingdom		77.7	15.5	1.9	1.4	0.1	0.1	3.0	0.3	4219	101	4320
Croatia		66.9	2.5	1.8	13.2	0.6	0.3	5.0	9.8	1057	0	1057
Turkey		52.6	3.4	2.4	2.2	0.0	9.1	29.7	0.7	2145	0	2145
Norway
Total		57.3	6.8	12.9	4.8	0.2	1.2	12.8	4.0	28537	13245	41782

Notes:

 Percentages are of clients whose primary drug is known (n) 

 (1) Last data available refer to 2005.  

 (2) Data refer to 2007. 

 See also 'General notes for interpreting data' on the Explanatory notes and help page. 

Sources:

 Reitox national reports 2009 — TDI TDI tables V. 1.0-2008, outpatient and inpatient treatment centres (question 13.1.1).  

• Download this data in Excel (.xls) format

(see the help page for information about formats etc.)